EE04833B1 - Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks - Google Patents

Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks

Info

Publication number
EE04833B1
EE04833B1 EEP200100503A EEP200100503A EE04833B1 EE 04833 B1 EE04833 B1 EE 04833B1 EE P200100503 A EEP200100503 A EE P200100503A EE P200100503 A EEP200100503 A EE P200100503A EE 04833 B1 EE04833 B1 EE 04833B1
Authority
EE
Estonia
Prior art keywords
tolperison
salt
preparing
form containing
pharmaceutical form
Prior art date
Application number
EEP200100503A
Other languages
English (en)
Estonian (et)
Inventor
Frantsits Werner
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of EE200100503A publication Critical patent/EE200100503A/xx
Publication of EE04833B1 publication Critical patent/EE04833B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100503A 1999-04-01 1999-11-16 Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks EE04833B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0059499A AT409083B (de) 1999-04-01 1999-04-01 Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
PCT/AT1999/000276 WO2000059508A1 (de) 1999-04-01 1999-11-16 Tolperison enthaltende, pharmazeutische zubereitung zur oralen verabreichung

Publications (2)

Publication Number Publication Date
EE200100503A EE200100503A (et) 2003-02-17
EE04833B1 true EE04833B1 (et) 2007-06-15

Family

ID=3494723

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100503A EE04833B1 (et) 1999-04-01 1999-11-16 Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks

Country Status (23)

Country Link
US (1) US6500455B1 (tr)
EP (1) EP1165081B1 (tr)
JP (1) JP2002541107A (tr)
AT (1) AT409083B (tr)
AU (1) AU1136400A (tr)
CA (1) CA2366841C (tr)
CZ (1) CZ20013404A3 (tr)
DE (1) DE59912101D1 (tr)
EE (1) EE04833B1 (tr)
ES (1) ES2168241T3 (tr)
HR (1) HRPK20010706B1 (tr)
HU (1) HUP0200669A3 (tr)
IL (2) IL145559A0 (tr)
NO (1) NO20014738L (tr)
NZ (1) NZ514129A (tr)
PL (1) PL197545B1 (tr)
PT (1) PT1165081E (tr)
RU (1) RU2223098C2 (tr)
SK (1) SK13642001A3 (tr)
TR (1) TR200102811T2 (tr)
UA (1) UA71613C2 (tr)
WO (1) WO2000059508A1 (tr)
YU (1) YU67501A (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300929A3 (en) * 2003-04-09 2005-06-28 Richter Gedeon Vegyeszet Analgetic and/or muscle relaxant pharmaceutical composition
DE10341923A1 (de) * 2003-09-11 2005-04-07 Heinl, Alexander, Dr.med. Verwendung von Tolperison
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de) * 2003-10-23 2005-05-25 Viatris Gmbh & Co. Kg Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
US20070249673A1 (en) * 2006-04-20 2007-10-25 Angelika Bodenteich Method for administering tolperisone
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
PT2061465E (pt) * 2006-08-23 2013-07-15 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8030518B2 (en) 2006-11-28 2011-10-04 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
HUP0700485A3 (en) * 2007-07-23 2010-01-28 Richter Gedeon Nyrt Pharmaceutical composition with controlled release containing tolperisone
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
US8865732B2 (en) 2008-03-21 2014-10-21 Novartis Ag Heterocyclic compounds and uses thereof
US20100249423A1 (en) * 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet
CN102438597A (zh) 2009-03-09 2012-05-02 丁内沙·沙蒂尔阿尔·帕特尔 一种选自中枢性作用肌弛缓药类型的化合物的新型缓释制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5340779A (en) * 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS58135806A (ja) * 1982-02-08 1983-08-12 Nippon Kayaku Co Ltd 多層コ−チング製剤
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPH0637389B2 (ja) * 1986-12-26 1994-05-18 北陸製薬株式会社 頻尿治療剤
JPH0720866B2 (ja) 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
MY115126A (en) * 1990-04-27 2003-04-30 Seikisui Chemical Co Ltd Percutaneously absorbable eperisone or tolperisone preparation.
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
TW209174B (tr) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
DE69220317T2 (de) * 1991-10-01 1997-10-16 Takeda Chemical Industries Ltd Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance

Also Published As

Publication number Publication date
HRP20010706A2 (en) 2003-02-28
PL197545B1 (pl) 2008-04-30
HRPK20010706B1 (en) 2004-12-31
ES2168241T1 (es) 2002-06-16
NO20014738L (no) 2001-10-23
ES2168241T3 (es) 2005-11-01
WO2000059508A1 (de) 2000-10-12
RU2223098C2 (ru) 2004-02-10
SK13642001A3 (sk) 2002-03-05
ATA59499A (de) 2001-10-15
IL145559A (en) 2008-12-29
NZ514129A (en) 2003-04-29
EP1165081B1 (de) 2005-05-25
PT1165081E (pt) 2005-08-31
HUP0200669A2 (hu) 2002-07-29
CA2366841C (en) 2008-10-07
AT409083B (de) 2002-05-27
EE200100503A (et) 2003-02-17
HUP0200669A3 (en) 2002-11-28
NO20014738D0 (no) 2001-09-28
PL351377A1 (en) 2003-04-07
CZ20013404A3 (cs) 2002-02-13
IL145559A0 (en) 2002-06-30
CA2366841A1 (en) 2000-10-12
EP1165081A1 (de) 2002-01-02
JP2002541107A (ja) 2002-12-03
YU67501A (sh) 2004-07-15
US6500455B1 (en) 2002-12-31
UA71613C2 (uk) 2004-12-15
AU1136400A (en) 2000-10-23
TR200102811T2 (tr) 2002-05-21
DE59912101D1 (de) 2005-06-30

Similar Documents

Publication Publication Date Title
EE04833B1 (et) Meetod suukaudselt manustatava, Tolperisoni või selle soola sisaldava farmatseutilise preparaadi valmistamiseks
NO20005415D0 (no) Antennesystem for brønnboring, samt fremgangsmÕte
TR200000520A3 (tr) 4-Fenil-piridin türevleri.
IT1317741B1 (it) Metodo per la preparazione di 5-cianoftalide.
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
ID30263A (id) Metode untuk penyegelan melingkar
BR0010106B1 (pt) dispositivo de manuseio de hastes de perfuração.
ID25682A (id) Metode untuk melelehkan kaca
ZA200005521B (en) Method for transferring easily-polymerizable substance.
PT1212320E (pt) Fenilpiperazinas como inibidores de reabsorcao de serotonina
MA26794A1 (fr) Derives de 5-phenyl-pyrimidine.
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
BR0011702B1 (pt) processo para preparação de derivados herbicidas.
IT1319251B1 (it) Metodo per la preparazione di 5-carbossiftalide.
IT1311921B1 (it) Composti farmaceutici.
EE200200050A (et) Benseenamiini derivaadid antikoagulantidena
EE200200171A (et) Polümorfne sool
EE04902B1 (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
FI110661B (fi) Menetelmä eloperäisen materiaalin, kuten rehun, säilömiseksi
FR2797443B1 (fr) Procede de prepartion de quinoleine-5,8-diones
IT1307225B1 (it) Sostanza per verruche.
IT1303260B1 (it) Procedimento per preparare composti indolici.
ES1042294Y (es) Envase perfeccionado.
IT1311599B1 (it) Scopa particolarmente per esterni.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20091116